Can You Get the Flu and Pneumonia Vaccine at the Same Time?

Getting a flu shot and a pneumococcal (pneumonia) vaccine in the same visit is safe, effective, and widely recommended by health authorities. Clinical trials and real-world surveillance data consistently show that co-administering the two does not meaningfully blunt the immune response to either one, though you can expect slightly more soreness or fatigue than you would from a single shot alone. The practice is common enough that many clinics and pharmacies offer both during the same appointment, and the biological connection between influenza and bacterial pneumonia makes a strong case for doing exactly that.

What the Safety Data Actually Shows

The most consistent finding across studies is that getting both vaccines on the same day produces more local reactions, like soreness and swelling at the injection site, than getting either one alone. In a large study of elderly recipients, local reactions occurred at a rate of about 284 per 1,000 in people who got only the flu vaccine, compared with 441 per 1,000 in those who received both the flu and pneumococcal vaccines together. Fever was uncommon in both groups but roughly doubled in the dual-vaccine group, from about 10 per 1,000 to 24 per 1,000. No serious reactions were observed in either group.¹

A post-marketing safety study in China found a similar pattern with some age-related nuance. Among people aged 60 and older, the difference in adverse reaction rates between co-administration and the pneumococcal vaccine alone was not statistically significant. In younger adults and children, co-administration did produce higher reaction rates, though the reactions were still mild.²

The takeaway is straightforward: you will probably feel a bit more run-down with two shots than with one, but the side effects stay in the mild-to-moderate range. If you are over 60, you may not even notice a difference. An extra day of arm soreness is a reasonable trade-off for the convenience of one trip and the protection of two vaccines working simultaneously.

Does Getting Both Affect How Well They Work?

A common concern is that the immune system might get “overwhelmed” by processing two vaccines at once, leading to a weaker response to one or both. The evidence does not support that worry. A study of 124 elderly community-dwelling adults found no difference in antibody levels, protection rates, or seroconversion rates for influenza whether the flu vaccine was given alone or alongside the 23-valent pneumococcal vaccine. There was a small, non-significant dip in pneumococcal antibody concentration in the co-administration group, but not enough to matter clinically. The researchers concluded that giving both vaccines simultaneously was safe, effective, and economically advantageous.³

More recent data on the newer 20-valent pneumococcal conjugate vaccine (PCV20) reinforces this. A phase 3 randomized trial compared people who received PCV20 and a quadrivalent flu vaccine at the same visit with those who received them separately. The co-administration group met noninferiority criteria for all 20 pneumococcal serotypes and all four influenza strains, meaning the immune response was just as strong whether the shots were given together or apart. Fatigue was somewhat more common in the co-administration group, with about 20% reporting mild fatigue compared with 11-13% in the separate groups, but this was not considered clinically significant.⁴

Your immune system is designed to handle exposure to thousands of foreign molecules daily. Two vaccines in different arms are well within its capacity. The slight uptick in fatigue reflects the immune system working harder, not struggling.

Why Both Vaccines Are Especially Valuable Together

There is a deeper reason to get these two vaccines at the same time, beyond convenience. Influenza and bacterial pneumonia are biologically intertwined. The flu virus damages the lining of the respiratory tract and disrupts the immune cells that normally keep bacteria in check. This creates an opening for bacteria like Streptococcus pneumoniae to establish infections that might not have gained a foothold otherwise.⁵

The problem runs deeper than simple tissue damage. The influenza virus triggers an intense interferon response as part of the body’s antiviral defense, and that same interferon surge actually impairs the ability of immune cells to fight bacteria. Phagocytes, the cells that normally engulf and destroy bacterial invaders, become less effective. The normal balance of microbes in the respiratory tract shifts. Bacteria that were peacefully coexisting suddenly have both a weakened host defense and new surfaces to cling to.⁶

Laboratory work has shown that when influenza and pneumococcal bacteria arrive simultaneously, the bacterial signals dominate the immune response, driving intense inflammation. When the virus arrives first and bacteria follow days later, the picture shifts: the prior viral infection “primes” the immune response in ways that amplify inflammation and promote tissue-damaging clot formation when the bacteria show up.⁷ Either way, the combination of flu followed by bacterial pneumonia is far more dangerous than either infection alone.

A large observational study of elderly people quantified what this means in real-world terms. Compared with unvaccinated individuals, those who had received both the flu and pneumococcal vaccines had roughly a 37% reduction in hospital admissions for influenza, a 29% reduction for pneumonia, and a 44% reduction for invasive pneumococcal disease. Receiving only one of the two vaccines provided some benefit, but the two together were clearly additive, and in-hospital mortality for pneumonia was significantly lower in the doubly vaccinated group.⁸

This additive protection makes intuitive sense once you understand the biology: the flu vaccine reduces the likelihood of the viral infection that would weaken your defenses, while the pneumococcal vaccine independently trains your immune system to fight the bacteria that would exploit any breach. Blocking both threats simultaneously is more protective than blocking either one alone.

A Note on Febrile Seizures in Young Children

There is one population where co-administration requires extra attention. In young children, receiving the inactivated flu vaccine and the pneumococcal conjugate vaccine (PCV13) at the same visit has been linked to a small increase in the risk of febrile seizures, which are seizures triggered by a rapid rise in body temperature.⁹ Febrile seizures are frightening to witness but are almost always harmless and do not cause lasting neurological damage.

Even with this small added risk, the American Academy of Pediatrics has maintained that both vaccines can still be given at the same visit, because the risk of missing one or both vaccinations altogether is considered a greater danger than the slight increase in febrile seizure risk. If your child has a history of febrile seizures, it is worth discussing timing with your pediatrician. For most children, the benefit of ensuring both shots happen outweighs the rare chance of a fever-related seizure.

Conjugate Versus Polysaccharide Pneumococcal Vaccines

When people talk about “the pneumonia vaccine,” they could mean a few different products, and which one you get affects the co-administration picture slightly. The two main categories are conjugate vaccines (like PCV13, PCV15, and PCV20) and polysaccharide vaccines (PPSV23). Conjugate vaccines attach bacterial sugars to a protein carrier, which produces a stronger and longer-lasting immune response and is the type given to young children. Polysaccharide vaccines use those sugars alone and are mainly used in older adults.

Most of the co-administration safety and efficacy data covers both types, and the results are reassuring across the board. The phase 3 trial showing noninferiority for PCV20 given alongside the flu shot specifically tested the newer conjugate approach.⁴ The older studies establishing safety in the elderly used the 23-valent polysaccharide vaccine.³ Either way, co-administration does not compromise the immune response.

If your vaccination schedule calls for both a conjugate and a polysaccharide pneumococcal vaccine (some adults receive PCV20 first, followed by PPSV23 later), the flu shot can accompany whichever pneumococcal dose you happen to be getting. Just make sure the vaccines go in different arms, or at least different injection sites on the same arm with several inches of separation. Your provider will handle that logistics automatically.

The Practical Case for Same-Day Vaccination

Beyond biology, there is a strong logistical argument for co-administration. Every additional appointment you need to make is another opportunity for the vaccination to not happen. Life gets busy, people forget, schedules conflict. A modeling study found that offering both vaccines in a single visit improved pneumococcal vaccination compliance enough to shift the cost-effectiveness ratio in favor of the dual strategy, at roughly $5,300 per quality-adjusted life-year gained. That is well below the threshold most health systems consider a good investment.¹⁰

Standing order programs, where nurses or pharmacists can administer certain vaccines without a specific physician order for each patient, have proven especially effective at getting both shots into arms during the same visit. These programs are economically favorable across a range of clinical settings.¹¹ Specialty clinics for patients with conditions like inflammatory bowel disease have reported significant jumps in vaccination rates simply by assessing vaccine status at each visit and offering same-day shots.¹²

For people with chronic conditions, immunosuppression, or complicated medication schedules, the same-day approach is particularly valuable. If you are already at the clinic, there is no good reason to come back a second time for a separate shot. Provider reminder tools that flag which vaccines a patient is due for have been shown to increase same-day vaccination rates, though the effect varies by clinic.¹³

One Counterpoint Worth Knowing

While the evidence for co-administration safety and convenience is robust, the effectiveness of pneumococcal vaccination itself is less straightforward than many people assume. A population-based cohort study in Catalonia looking at real-world outcomes found that neither PCV13 nor PPSV23 was effective in preventing hospitalized pneumococcal pneumonia, all-cause pneumonia, or death from pneumonia in the general study population. In fact, receipt of either pneumococcal vaccine was associated with a slightly higher risk of pneumonia-related hospitalization after statistical adjustment, though this likely reflects the fact that people at highest risk are the ones most likely to get vaccinated, a common bias in observational studies.¹⁴

This does not mean pneumococcal vaccines are useless. Clinical trials with more controlled designs have demonstrated protection, and the observational study from Spain had important limitations, including the healthy-user bias just mentioned. But it does serve as a reminder that vaccines work in the context of populations and individual risk profiles, and that real-world effectiveness can look different from trial efficacy. What it does not change is the co-administration question: if you are going to get a pneumococcal vaccine, there is no reason to schedule it on a separate day from your flu shot.

Needle Anxiety and the Multiple-Shot Visit

For children especially, getting two injections in one visit raises a concern that has nothing to do with immunology: needle fear. Research has found that the number of same-day injections a child receives at preschool age is associated with greater needle fear years later. Each additional injection at a single visit roughly tripled the odds that the child would report high fear of needles as a preadolescent, and that fear in turn predicted lower uptake of later vaccines like HPV. The total number of lifetime injections or the number received at other ages did not have the same effect; it was specifically the clustering of multiple shots on one occasion that seemed to matter.¹⁵

This is a real consideration, particularly for parents deciding how many vaccines to bundle into a single pediatric visit. For adults, the calculation is different. Most adults can tolerate two shots without developing lasting anxiety, and the missed-dose risk from splitting appointments is the bigger concern. For young children, clinicians sometimes spread out non-urgent vaccines over two closely spaced visits to reduce the stress of multiple injections at once, while still making sure all doses get completed. If needle fear is a known issue for your child, raising it with your pediatrician can help you find a schedule that balances protection with comfort.

1
PubMed. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly
2
PubMed Central. Post-marketing Safety Surveillance of 23-Valent Pneumococcal Polysaccharide Vaccine Administered Alone and Concomitantly with Influenza Vaccine in Individuals Aged 2 Years and Older in China
3
PubMed. Simultaneous influenza and pneumococcal vaccination in elderly individuals
4
ScienceDirect / Vaccine (Elsevier). Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial
5
PubMed Central. Bench-to-bedside review: bacterial pneumonia with influenza – pathogenesis and clinical implications
6
PubMed Central. Current insights into bacterial secondary infection following influenza A virus infection
7
PubMed Central. Divergent macrophage responses to Influenza A virus and Streptococcus pneumoniae
8
European Respiratory Journal. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
9
AAP News. PCV13 and influenza vaccines still can be given at same visit
10
PubMed Central. Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds
11
PubMed Central. Cost-effectiveness of pneumococcal and influenza vaccination standing order programs
12
Gastroenterology & hepatology. Influenza and Pneumococcal Vaccination Rates in Patients With Inflammatory Bowel Disease
13
PubMed. A comprehensive patient assessment and physician reminder tool for adult immunization: effect on vaccine administration
14
PubMed Central. Real world effectiveness of antipneumococcal vaccination against pneumonia in adults: a population-based cohort study, Catalonia, 2019
15
PubMed Central. The number of injected same-day preschool vaccines relates to preadolescent needle fear and HPV uptake